Sector revisions Arrowhead Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 11/06/2026 BST			5-day change	1st Jan Change
74.41 ^USD	+5.20%		-1.00%	+12.08%

06-10	Arrowhead Pharmaceuticals, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-10-2026 07:58 AM
05-27	Arrowhead Pharmaceuticals Presents New Clinical Data on RNAi-based Obesity and MASH Candidate ARO-INHBE at EASL 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Visibility	Nbr of analysts
ARROWHEAD PHARMACEUTICALS, INC.		12
ARGENX SE		15
WUXI APPTEC CO., LTD.		16
BIONTECH SE		19
INSMED INCORPORATED		21
WUXI BIOLOGICS (CAYMAN) INC.		22
GENMAB A/S		15
EXELIXIS, INC.		16
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.		17
PHARMAESSENTIA CORPORATION		6
MADRIGAL PHARMACEUTICALS, INC.		14
AKESO, INC.		20
SUMMIT THERAPEUTICS INC.		13
NUVALENT, INC.		16
CYTOKINETICS, INCORPORATED		20
IMMUNITYBIO, INC.		3
REMEGEN CO., LTD.		15
BIOCON LIMITED		20
SAMSUNG EPIS HOLDINGS CO., LTD.	-	1
VAXCYTE, INC.		9
Average		14
Weighted average by Cap.		16